In Episode #2 ,“Inside Columbia University’s BioMedX : A Talk with Meghan Pinezich,” Gregory Montalbano, CEO of MIDI, sits down with Meghan Pinezich, an Executive Team member at Columbia BioMedX. Columbia BioMedX, formerly known as the Columbia-Coulter Research Partnership, is a biomedical engineering technology accelerator at Columbia University. With a background in Chemical Engineering from the University of Virginia and Biomedical Engineering from Columbia, Meghan has also completed a PhD in Stem Cell and Tissue Engineering.
Episode Highlights:
- Columbia BioMedX Overview: Discover the mission and structure of Columbia BioMedX’s Accelerator program and its role within Columbia’s Lab-to-Market Accelerator network.
- Mentoring and Support: Learn about BioMedX’s methods for mentoring and supporting entrepreneurial groups in medical, scientific, and biotechnology applications.
- Network Support: Explore the extensive corporate, university, industry, and venture partner networks that provide support to BioMedX members.
- Application Insights: Find out what BioMedX looks for in startup members and how to apply to their programs.
- Innovation on the Horizon: Hear about new initiatives and breakthroughs expected from BioMedX’s entrepreneurial members, with real-world examples from Meghan’s experiences as a participant and now as an Executive Program Manager.
Why Listen?
This episode is a must-listen for entrepreneurs, innovators, and professionals in the biomedical and biotech fields. Gain a detailed understanding of how Columbia BioMedX operates, its support systems, and the exciting opportunities available for startups within its accelerator program.
Be at the Forefront of Medical Device Innovation
Stay ahead in medical and scientific innovation by learning from the inner workings of Columbia BioMedX and understanding how their accelerator program fosters groundbreaking developments.
Listen Now
Tune in to uncover the secrets of successful acceleration at Columbia BioMedX, learn how to navigate their application process, and get inspired by the upcoming breakthroughs from their member network.